Biodexa Pharmaceuticals Plc (BDRX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 | Q4'21 | Q2'21 | Q4'20 | Q2'20 | Q4'19 | Q2'19 | Q4'18 | Q2'18 | Q4'17 | Q2'17 | Q4'16 | Q2'16 |
|---|
| Cash from Operations | -2.33M | -3.3M | -7.45M | -4.81M | -2.94M | -3.88M | -3.51M | -3.54M | -2.9M | -3.11M | -2.21M | -7.09M | -1.93M | -4.56M | -5.68M | -7.76M | -2.84M | -10.11M | -5.04M | -8.04M |
| Operating CF Margin % | - | - | - | - | -3548.19% | -1302.35% | -1519.05% | -756.2% | -1638.42% | -775.06% | -1264.57% | -4219.05% | -868.47% | -1009.07% | -409.29% | -1414.39% | -550.19% | -2138.27% | 139.51% | -272.59% |
| Operating CF Growth % | 68.8% | 31.27% | -153.11% | -23.86% | 16.07% | -9.66% | -21% | -13.87% | -31.04% | 56.15% | -14.78% | -55.4% | 66.09% | 41.26% | -100.25% | 23.23% | 43.69% | -25.73% | 29.13% | -51.57% |
| Net Income | -2.56M | -3.81M | -2.42M | -3.31M | -3.51M | -3.57M | -4.59M | -3.06M | -2.31M | -3.15M | -4.77M | -17.42M | -5.67M | -4.42M | -3.62M | -11.41M | -7.03M | -9.03M | -11.96M | -8.21M |
| Depreciation & Amortization | 48.7K | 140K | 118K | 136K | 140K | 143K | 161K | 182K | 224K | 179K | 654K | 563K | 644K | 641K | 183K | 928K | 1.28M | 1.28M | 2.2M | 2.15M |
| Stock-Based Compensation | 0 | 97K | 133K | 150K | 13K | 15K | 23K | 100K | 52K | 37K | 1K | -473K | -60K | 26K | 93K | -93K | -271K | 271K | 0 | 75K |
| Deferred Taxes | 0 | 0 | -250K | 0 | 0 | -118K | -254K | 124K | -424K | 822K | -987K | 966K | -1.7M | -87K | 218K | -218K | 1.08M | 93K | 0 | -638K |
| Other Non-Cash Items | -1.56M | -1.78M | -2.6M | -487K | 151K | -367K | 506K | -528K | -1.24M | 689K | 865K | 10.83M | 3.2M | -870K | -3.58M | 2.5M | 3.99M | -2.27M | 4.63M | -2.63M |
| Working Capital Changes | 1.75M | 2.05M | -2.44M | -1.3M | 262K | -104K | 396K | -232K | 372K | -859K | 1.04M | -590K | 1.74M | 61K | 1.23M | 311K | -806K | -364K | 91K | 563K |
| Change in Receivables | 642.85K | 2.05M | -4.68M | -1.3M | 262K | 103K | 231K | -224K | 372K | -859K | 986K | -493K | 664K | 61K | 654K | 376K | -745K | -223K | 0 | 891K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 412K | -65K | -61K | -141K | 91K | -328K |
| Change in Payables | 1.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -308.93K | -339K | 156K | -754K | -285K | 20K | -203K | -17K | -131K | -147K | 2.66M | -88K | -2.83M | -974K | 9.36M | -316K | -263K | -1.21M | -607K | -595K |
| Capital Expenditures | -326.82K | -2K | -9K | 0 | -22K | -4K | -29K | -33K | -131K | -189K | -120K | -89K | -299K | -20K | 73K | -317K | -267K | -440K | -595K | -752K |
| CapEx % of Revenue | - | - | - | - | 26.51% | 1.34% | 12.55% | 7.05% | 74.01% | 47.13% | 68.57% | 52.98% | 134.68% | 4.42% | 5.26% | 57.74% | 51.74% | 93.02% | -16.46% | 25.48% |
| Acquisitions | 17.89K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -947K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -337K | 165K | -754K | -263K | 24K | -174K | 16K | 0 | 42K | 2.78M | 1K | 15K | -954K | 9.29M | 1K | 4K | -767K | -12K | 157K |
| Cash from Financing | 7.18M | 6.01M | 3.91M | 4.64M | 3.97M | 6.25M | 125K | -78K | 8.89M | -81K | 2.7M | 385K | 6.5M | 12.23M | -6.16M | -311K | 10.38M | -98K | 15.42M | -164K |
| Debt Issued (Net) | -447.23K | -95K | 245K | -93K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.86M | 0 | -5.88M | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 7.65M | 0 | 8.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -22.18K | 6.11M | -4.64M | 4.74M | 3.97M | 6.25M | 125K | -78K | 8.89M | -81K | 2.7M | 385K | -11.47M | 12.23M | -276K | -311K | 10.38M | -98K | 15.42M | -164K |
| Net Change in Cash | 4.41M | 4.04M | -5.05M | 5.05M | 372K | 1.2M | -1.79M | 6.42M | 2.93M | -1.67M | 1.61M | -3.3M | 1.95M | 3.32M | -2M | -4.43M | 3.51M | -5.71M | 5.19M | -4.47M |
| Free Cash Flow | -2.33M | -3.31M | -8.23M | -4.81M | -2.97M | -3.88M | -3.54M | -3.57M | -3.03M | -3.3M | -2.33M | -7.18M | -2.23M | -4.58M | -5.61M | -8.08M | -3.11M | -10.55M | -5.64M | -8.8M |
| FCF Margin % | - | - | - | - | -3574.7% | -1303.69% | -1531.6% | -763.25% | -1712.43% | -822.19% | -1333.14% | -4272.02% | -1003.15% | -1013.5% | -404.03% | -1472.13% | -601.94% | -2231.29% | 155.98% | -298.07% |
| FCF Growth % | 71.74% | 31.23% | -177.32% | -23.73% | 16.14% | -8.76% | -16.73% | -8.34% | -29.92% | 54.06% | -4.76% | -56.67% | 60.32% | 43.32% | -80.68% | 23.42% | 44.9% | -19.99% | 22.81% | -45.63% |
| FCF per Share | -10.30 | -13.08 | -132.81 | -1939.87 | -98900.00 | -555000.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | -999999.00 | - | - | - | - | - | - | - | - | - |
| FCF Conversion (FCF/Net Income) | 0.91x | 0.87x | 3.08x | 1.45x | 0.84x | 1.09x | 0.76x | 1.16x | 1.26x | 0.99x | 0.46x | 0.41x | 0.41x | 1.03x | 1.20x | 1.38x | 0.50x | 1.68x | -0.63x | 0.98x |
| Interest Paid | 0 | 10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |